COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT00515866
Brief Title: Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer

First Submitted : August 13, 2007
First Submitted that Met QC Criteria : August 13, 2007
First Posted : August 14, 2007 (Estimate)

Last Update Submitted that Met QC Criteria : December 19, 2013
Last Update Posted : December 20, 2013 (Estimate)